Appak Özgür, Özarslan Derya, Nazlı Arzu, Sayiner Ayca Arzu
Faculty of Medicine, Department of Medical Microbiology, Division of Medical Virology, Dokuz Eylul University, Izmir, Turkey.
Faculty of Medicine, Department of Medical Microbiology, Dokuz Eylul University, Izmir, Turkey.
J Trop Med. 2025 Jan 31;2025:5111633. doi: 10.1155/jotm/5111633. eCollection 2025.
This study aimed to evaluate the effectiveness of the algorithm used in HIV diagnosis and to propose an effective new algorithm for rapid diagnosis. In accordance with CDC algorithm, our laboratory uses Architect HIVAg/Ab for screening and Geenius HIV1/2 and Artus HIVirus-1 QS-RGQ for confirmation. The Geenius test was used as a reflex and the HIV-1-RNA required clinician order. The HIVAg/Ab test was performed in 82,882 sera and found to be reactive in 262 (0.3%). HIV-antibody confirmatory testing was performed on 79% of samples with a reactive screening test, and the presence of HIV-1 antibodies was confirmed in 51% (105/206). Half of the samples with positive-screening but negative-antibody confirmatory results were tested for HIV1-RNA, and viremia was detected in 5, confirming acute HIV1 infection. HIV1-RNA was not ordered for 49 samples with positive-screening and negative antibody-confirmation tests, and 16 of these were considered false-reactive by the clinician. The Geenius assay result was indeterminate in 1.45% (3/206) of the samples. In the algorithm, the number of Geenius tests would have been reduced by 25% if HIV-1-RNA had been applied as a reflex test to HIV-Ag/Ab positive samples and Geenius testing had been performed on RNA negative samples. A retrospective analysis showed that the HIV diagnostic algorithm was not fully implemented. An important factor was that clinicians did not order HIV-1-RNA-PCR from ELISA reactive and Geenius test negative patients. Requesting HIV-1 RNA PCR as a reflex test is thought to prevent patient losses and shorten the turnaround time of the HIV diagnosis.
本研究旨在评估用于HIV诊断的算法的有效性,并提出一种有效的快速诊断新算法。根据美国疾病控制与预防中心(CDC)的算法,我们实验室使用Architect HIVAg/Ab进行筛查,使用Geenius HIV1/2和Artus HIVirus-1 QS-RGQ进行确认。Geenius检测用作补充检测,HIV-1-RNA检测需要临床医生下达医嘱。对82,882份血清进行了HIVAg/Ab检测,发现其中262份(0.3%)呈反应性。对79%筛查呈反应性的样本进行了HIV抗体确认检测,51%(105/206)的样本确认存在HIV-1抗体。对一半筛查呈阳性但抗体确认结果为阴性的样本进行了HIV1-RNA检测,其中5份检测到病毒血症,确诊为急性HIV1感染。对于49份筛查呈阳性且抗体确认检测为阴性的样本未进行HIV1-RNA检测,临床医生认为其中16份为假反应性。Geenius检测结果在1.45%(3/206)的样本中不确定。在该算法中,如果将HIV-1-RNA作为对HIV-Ag/Ab阳性样本的补充检测,并对RNA阴性样本进行Geenius检测,Geenius检测的数量将减少25%。回顾性分析表明,HIV诊断算法未得到充分实施。一个重要因素是临床医生未对ELISA呈反应性且Geenius检测为阴性的患者下达HIV-1-RNA-PCR检测医嘱。将HIV-1 RNA PCR作为补充检测被认为可以避免患者漏诊并缩短HIV诊断的周转时间。